Vistagen Therapeutics (VTGN) EBITDA Margin (2011 - 2026)
Vistagen Therapeutics' EBITDA Margin came in at -900.81% for fiscal Q1 2027 (quarter ended Jun 30, 2026), up 5559.84 percentage points from -6460.66% a year earlier and up 2683.06 percentage points from the prior quarter.
Vistagen Therapeutics (VTGN) EBITDA Margin (2011 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Vistagen Therapeutics reported EBITDA Margin of -2775.90%, up 6433.08 percentage points year-over-year; for FY2026 (ended Mar 31, 2026), it was -5668.01%, up 5818.21 percentage points from FY2025.
- EBITDA Margin carries a five-year change of -4032.74 percentage points (FY2021 to FY2026).
- Going back by fiscal year, EBITDA Margin was -11486.21% in FY2025 (-8394.67 pp), -3091.54% in FY2024 (+22960.44 pp) and -26051.98% in FY2023.
- The fiscal Q1 2027 figure represents the highest quarterly EBITDA Margin since fiscal Q3 2017.
- Year-over-year, EBITDA Margin increased in four of the last six quarters, with an average year-over-year change of +579.30 percentage points.
- The fastest year-over-year change in EBITDA Margin over five years came in fiscal Q1 2026 (a gain of 7940.53 percentage points), and the weakest in fiscal Q1 2025 (a drop of 10918.19 percentage points).
- Business Quant data shows VTGN's EBITDA Margin at -3583.87% (Q4 2026), -6433.00% (Q3 2026) and -7751.94% (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 39.10% |
| 10 | Vistagen Therapeutics | 13.76 Mn | 13.76 Mn | - | -900.81% |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -900.81% |
| Mar 31, 2026 | -3,583.87% |
| Dec 31, 2025 | -6,433.00% |
| Sep 30, 2025 | -7,751.94% |
| Jun 30, 2025 | -6,460.66% |
| Dec 31, 2024 | -6,444.87% |
| Sep 30, 2024 | -7,754.10% |
| Jun 30, 2024 | -14,401.19% |
| Mar 31, 2024 | -6,906.10% |
| Dec 31, 2023 | -1,910.71% |
| Sep 30, 2023 | -2,249.67% |
| Jun 30, 2023 | -3,483.00% |
| Mar 31, 2023 | -6,934.77% |
| Dec 31, 2022 | -5,408.83% |
| Sep 30, 2022 | -1,954.76% |
| Jun 30, 2022 | -6,365.95% |
| Dec 31, 2021 | -2,931.65% |
| Sep 30, 2021 | -3,565.17% |
| Jun 30, 2021 | -2,178.67% |
| Mar 31, 2021 | -1,397.90% |
Vistagen Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "VTGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=VTGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();